Emis Share Price (EMIS)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Emis Group	LSE:EMIS	London	Ordinary Share	GB00B61D1Y04	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-4.50p	-0.49%	921.50p	922.00p	926.00p	934.00p	912.00p	921.00p	78,748	16:35:23

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Software & Computer Services	158.7	25.3	30.4	30.3	583.41

Related Shares
Micro Focus International (MCRO), Sage Group (SGE), Progility (PGY), On-line Plc (ONL)

Emis (EMIS) Latest News

Emis News

Date	Time	Source	Headline
14/9/2017	15:26	UKREG	EMIS Group PLC Director/PDMR Shareholding
04/9/2017	14:35	UKREG	EMIS Group PLC Director Dealings - Award of Share Options
01/9/2017	11:25	ALNC	TAKING AIM: N+1 Waiting For "Tick Up" In EMIS Outlook, Numis "Patient"
01/9/2017	09:37	ALNCF	Alliance News Flash Headline
01/9/2017	08:02	ALNC	EMIS Keeps Outlook, Ups Dividend 10% As Profit Dips In First Half
01/9/2017	07:00	UKREG	EMIS Group PLC Half-year Report
16/8/2017	17:44	UKREG	EMIS Group PLC Director/PDMR Shareholding
18/7/2017	09:27	ALNC	EMIS Group Says Interim Trading In Line Despite NHS Funding Pressures
18/7/2017	07:00	UKREG	EMIS Group PLC Trading Statement
18/7/2017	07:00	UKREG	EMIS Group PLC Restatement of segmental reporting

More Emis News

Emis Takeover Rumours

Emis (EMIS) Share Charts

1 Year Emis Chart

1 Month Emis Chart

Intraday Emis Chart

Emis (EMIS) Discussions and Chat

Emis Forums and Chat

Date	Time	Title	Posts
07/9/2017	23:00	EMIS - Healthcare IT	441

Add a New Thread

Emis (EMIS) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
16:09:06	921.41	812	7,481.83	O
16:08:02	924.01	1,243	11,485.45	O
15:50:03	922.60	898	8,284.95	O
15:35:23	921.50	1,754	16,163.11	UT
15:29:53	926.00	3	27.78	AT

View all Emis trades in real-time

Emis (EMIS) Top Chat Posts

Date	Subject
26/9/2017 09:20	Emis Daily Update: Emis Group is listed in the Software & Computer Services sector of the London Stock Exchange with ticker EMIS. The last closing price for Emis was 926p. Emis Group has a 4 week average price of 896p and a 12 week average price of 873p. The 1 year high share price is 1,015p while the 1 year low share price is currently 793p. There are currently 63,311,396 shares in issue and the average daily traded volume is 87,252 shares. The market capitalisation of Emis Group is £583,414,514.14. Read Full Thread Reply
05/3/2017 16:47	garry1000: I hear that 10% of the work force is getting cut to boost the share price Read Full Thread Follow Reply
26/1/2017 15:45	waterloo01: Sorry been out of these awhile but the £10m figure taken from header bar here, however looking at last years full numbers (2015) the profit for the year was £5.3m (so 100 x) I'm probably working out incorrectly? htTp://uk.advfn.com/stock-market/london/emis-EMIS/share-news/EMIS-Group-PLC-Final-Results/70778496 Read Full Thread Follow Reply
26/1/2017 14:56	aishah: TechMarketView: EMIS battles headwinds in NHS IT market Healthcare software and services provider EMIS describes an “increasingly difficult environment” in the UK market in today’s trading update. Although EMIS’ overall performance for the year to the end of December was in line with the Board’s expectations, it’s clear that the severe pressures on NHS funds and a pause in procurement whilst the NHS’ Sustainability and Transformation Plans (STPs) were published have made it tough going. EMIS’ share price dipped some 6% on the news in early trading to c887p. We’ll need to wait for the full results in March to see the figures, but the headlines suggest that in Primary Care, EMIS’ heartland, it is maintaining market share and in Community, Children’s and Mental Health it is gaining market share. Secondary Care was most affected by the pressures on NHS funds but it performed largely in line with expectations thanks to the measures taken in the first half of 2016 (see here). In contrast, Specialist Care has been impacted by “operational inefficiencies”; and “additional costs associated with the implementation of its new contracts”, such that EMIS is considering a non-cash impairment charge to reflect the delay in contribution created by those additional costs. This is the division that offers image management and storage for the ophthalmology market, which requires rather a different business model to the software sales that EMIS is accustomed to. EMIS is focused on improving the profit profile of these new contracts but there’s clearly a risk that this move away from its software ‘knitting̵7; becomes an unwelcome and unprofitable distraction for the group. Whatever happens with Specialist Care, 2017 is set to be a busy, and we suspect challenging, year for EMIS. Q1 will see EMIS reorganise internally to bring primary, community and secondary care under common leadership, mirroring the NHS’ need to deliver more integrated care. And it’s continuing its search for a successor to CEO Chris Spencer who announced in December that he intends to retire by the end of the year (see here). ‘HeadwindsR17; will also remain a feature of the NHS IT market, but EMIS says it is confident of overcoming these and delivering a positive performance in 2017. Read Full Thread Follow Reply
31/12/2015 10:28	spong_1: Rampmeister, thanks for the info!Was wondering why the share price had been so flat the last few months.I think the trading update it's early March, so will definitely get back in before then... Read Full Thread Follow Reply
10/11/2015 19:57	ihatemms: Reddave- if you had waited around when they put staffline into their portfolio you would have paid an extra £2 per share (£10 to £12 within a week). You've got to get an initial holding in case the share price bolts off never to return as in the case of staff line.I bought a small amount of emis on t20 high initially but bought a lot more when it dropped back into the mid 10.50 .l then sold the initial purchase on the way back up again. That way I covered myself. Read Full Thread Follow Reply
06/4/2015 23:25	strollingmolby: I see EMIS will be presenting at the next AIM Investor Focus event, on 21 April. The companies selected to present at previous events have a strong track record of dividend increases and share price growth, so the selection of EMIS could be a lead indicator of more to come after the last twelve months: HTTP://www.blackthornfocus.com/events/aim-investor-focus/april-2015 AIM Investor Focus has run since 2012. In total, 26 companies have participated at the event. Of the 26 companies that have presented, 20 have gone on to increase their dividend to shareholders at each subsequent opportunity. Read Full Thread Follow Reply
12/5/2014 21:44	xjhoward: Shares mag buy recommendation:EMIS plugged into digital healthNHS software supplier poised for overdue re-ratingAnalysts see potential for 35% share price upside at healthcare software supplier EMIS (EMIS:AIM) over the next six to 12 months. They expect the company to enjoy a strong re-rating as the market properly recognises the growth potential of its digital services supplied to the NHS.The £402 million cap Leeds-based company has won favourable terms as part of the GP Systems of Choice (GPSoC) framework agreement that will see it earn more on increased usage of the EMIS Web suite and digital patient records. This win was hinted at by chief executive officer Chris Spencer in December (see Griller, Shares, 19 Dec '13).But while the market anticipates EMIS Web will fuel immediate growth, new opportunities are also emerging. The company is building momentum in the UK community pharmacies space through its Rx suite, while opportunities are seen in community health, hospital pharmacy, accident and emergency (A&E) departments and mental health. Read Full Thread Follow Reply
09/5/2014 08:19	grahamg8: Mach100 being quiet may be good as it is easier to read considered comments without trawling through masses of garbage. My take on EMIS is that it has a pretty good track record. Growing revenue, operating profit, eps and dps. So this is a growth company and is currently on a P/E of 19.6, yield of 2.40% and cover of 2.125x on a share price of 666p. All well and good. To be more precise the growth in sales is 24%pa, eps 12%pa and dps 14%pa non compounded over three years. The big unknown is the investment of £57.5m in Ascribe -RNS 13/09/13. This could make or break EMIS as there is now a lot of debt on the books which is only going to be paid for if profitable sales result. If we trust the managers to continue to deliver then we invest; if the risks look too great then we sell up. Personally I'm on the fence, happy to hold at the current share price and see which way the story unfolds over the following months. Read Full Thread Follow Reply

Emis share price data is direct from the London Stock Exchange

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:42 V: D:20170926 20:14:45